Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $36.5000 (0.7%) ($36.5000 - $36.5000) on Thu. Apr. 13, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.81% (three month average) | RSI | 65 | Latest Price | $36.5000(0.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.6% a day on average for past five trading days. | Weekly Trend | HALO advances 1.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IFRA(40%) IWO(38%) XBI(38%) IBB(36%) IWM(35%) | Factors Impacting HALO price | HALO will decline at least -1.405% in a week (0% probabilities). VXX(-15%) UUP(-13%) VIXM(-11%) TBT(-8%) IGOV(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.405% (StdDev 2.81%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $36.94(-1.19%) | 10 Day Moving Average | $37.34(-2.25%) | 20 Day Moving Average | $36.29(0.58%) | To recent high | -31.5% | To recent low | 11.1% | Market Cap | $4.989b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |